Vascugen Revenue and Competitors
Estimated Revenue & Valuation
- Vascugen's estimated annual revenue is currently $1.4M per year.
- Vascugen's estimated revenue per employee is $155,000
Employee Data
- Vascugen has 9 Employees.
- Vascugen grew their employee count by -25% last year.
Vascugen's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Assoc. Director R&D | Reveal Email/Phone |
3 | Project Manager | Reveal Email/Phone |
Vascugen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 5 | -17% | N/A | N/A |
#2 | $5.7M | 37 | 6% | N/A | N/A |
#3 | $10.2M | 66 | 6% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.6M | 49 | -2% | N/A | N/A |
#7 | $0.8M | 5 | -17% | N/A | N/A |
#8 | $7.9M | 51 | 6% | N/A | N/A |
#9 | $37.7M | 243 | -2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Vascugen?
Vascugen is an induced pluripotent stem cell (iPSC) therapy company advancing its novel vasculogenic cell technology to develop and manufacture engineered vascular cells. Our vasculogenic cells have the potential to directly address ischemic disease conditions and to serve as a novel platform for delivery of therapeutic payloads in cardiovascular, solid tumor, and other indications. Vascugen's research and development facility includes an integrated manufacturing facility for early-stage clinical manufacture of our products.
keywords:N/AN/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 9 | -44% | $18M |
#2 | $0.7M | 9 | 0% | N/A |
#3 | $0.7M | 9 | 0% | N/A |
#4 | $75M | 9 | 0% | N/A |
#5 | $0.7M | 9 | -44% | N/A |